Folic Acid or Leucovorin for Methotrexate? Key Differences
At a Glance
Folic acid is usually taken on a routine schedule to reduce common side effects of low-dose weekly methotrexate. Leucovorin is an active, clinician-timed rescue medicine used after high-dose methotrexate or when toxicity or overdose occurs; do not substitute one for the other.
In this answer
3 sections
If you are taking methotrexate, your care team will usually prescribe a folate supplement. While they sound similar, folic acid and leucovorin (also known as folinic acid) serve entirely different purposes depending on how and why methotrexate is being used.
The central difference is their role: regular folic acid is a routine preventative supplement used to reduce everyday side effects of low-dose methotrexate [1][2]. Leucovorin, which is an already-active form of folate, is a clinician-directed “rescue” medicine used to protect healthy cells after high-dose chemotherapy or during an emergency methotrexate overdose [3][4].
Emergency Warning
If you accidentally take an extra dose of methotrexate, or if you took it daily instead of weekly, do not wait for symptoms.
- Contact your prescriber, local poison center, or go to the nearest emergency department immediately [4].
- Do not take extra methotrexate, folic acid, or leftover leucovorin to try to fix it on your own.
- Have your methotrexate bottle, exact dose taken, and list of other medications ready when you call.
The Biological Difference: Active vs. Inactive Folate
Folate (vitamin B9) is required for cells to function and divide. The body uses an enzyme called dihydrofolate reductase (DHFR) to convert regular dietary folate into its active, usable form.
Methotrexate strongly blocks this DHFR enzyme [3].
- Folic Acid relies on the DHFR enzyme to become active. During low-dose methotrexate therapy, taking routine folic acid helps replenish your body’s overall folate pools, which can gently reduce side effects without undoing the complex anti-inflammatory benefits of the methotrexate [5][6].
- Leucovorin is already in the active (reduced) form. It completely bypasses the blocked DHFR enzyme, directly entering cells to restore folate supplies [3][7]. Because it is so potent, it is used strictly under medical supervision so that it protects healthy cells without accidentally protecting cancer cells or fully canceling out the treatment [8].
Folic Acid vs. Leucovorin: A Comparison
| Feature | Folic Acid | Leucovorin (Folinic Acid) |
|---|---|---|
| Typical Use | Low-dose methotrexate (e.g., rheumatoid arthritis, psoriasis, Crohn’s) [2] | High-dose oncology treatment or low-dose toxicity/overdose [4][8] |
| Main Purpose | Routine prevention of side effects | Rescue treatment to protect normal cells from methotrexate toxicity |
| How it Works | Needs conversion by the body | Already active; bypasses methotrexate’s block |
| Schedule | Often daily (except on methotrexate day) or once weekly, as prescribed [2] | Precisely timed by a clinical protocol, based on blood levels and kidney function |
| Can it Reverse Damage? | No. It is a slow, preventative measure. | No. It can help protect cells, but cannot instantly reverse organ damage that has already occurred. |
Folic Acid: Routine Support
For inflammatory diseases, methotrexate is typically taken once a week at a low dose. Alongside this, your doctor will prescribe a specific folic acid schedule.
Taking folic acid as prescribed may reduce the likelihood of common side effects, such as mouth sores, gastrointestinal upset, and liver injury (elevated liver enzymes) [1]. It can also help you stay on the medication comfortably for longer [1]. However, folic acid does not prevent all possible side effects, such as serious drops in blood cell counts or lung toxicity, which is why regular monitoring is still required [9].
Important: Only take folic acid according to your prescribed schedule. Do not alter the dose, add over-the-counter supplements, or double a missed dose without consulting your clinician [10].
Leucovorin: Clinician-Directed Rescue
Leucovorin is not for routine use with low-dose methotrexate. It is a rescue therapy used in specific, medically supervised situations:
- High-Dose Oncology Protocols: In cancer care, high doses of methotrexate are given to destroy tumor cells. Following the infusion (often starting 24 to 36 hours later, though it varies by protocol), leucovorin is administered to rescue healthy cells [8][11]. The exact dose and timing are carefully adjusted based on the patient’s kidney function and the concentration of methotrexate remaining in their blood [8].
- Methotrexate Toxicity or Overdose: If a patient accidentally takes too much low-dose methotrexate, or if their kidneys suddenly struggle to clear the drug (which can happen due to dehydration, kidney impairment, or interacting drugs like certain antibiotics), leucovorin may be used as an emergency intervention [4][12].
Important: Leucovorin is not an instant “off switch.” It cannot remove methotrexate from your body or instantly heal tissue injury that has already happened. In an emergency, your care team may also use IV fluids, medications to protect your kidneys, or in extreme cases, a drug called glucarpidase [13][14].
Monitoring and Recognizing Toxicity
Toxicity can sometimes occur even if you take your medication correctly, especially if you become dehydrated, your kidney function drops, or you start a conflicting medication [15].
Your clinician will regularly check your complete blood count (CBC), liver enzymes, and kidney function (creatinine/eGFR) to catch problems early [9][16]. Between visits, seek immediate medical attention if you experience:
- Fever, chills, sore throat, or other signs of infection
- Rapidly worsening mouth ulcers
- Unusual bruising or bleeding
- Severe vomiting, diarrhea, or dehydration
- Significantly reduced urine output or dark urine/jaundice
- Sudden shortness of breath or new cough
- Confusion or marked weakness
Common questions in this guide
What is the difference between folic acid and leucovorin when taking methotrexate?
Can I use leucovorin instead of folic acid with low-dose methotrexate?
How should I take folic acid with methotrexate?
What should I do if I take too much methotrexate or take it daily by mistake?
How is methotrexate toxicity monitored?
Does leucovorin immediately reverse methotrexate toxicity?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my specific weekly methotrexate dose, am I taking the right amount and schedule of folic acid to help prevent side effects?
- 2.How frequently will we monitor my complete blood count, liver tests, and kidney function (creatinine/eGFR) to check for toxicity that may not cause symptoms early?
- 3.Which laboratory results or specific symptoms would indicate I might have methotrexate toxicity and should stop taking the drug?
- 4.If methotrexate needs to be held due to an illness or an interacting medicine, when and how should it safely be restarted?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (16)
- 1
Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis: A Systematic Review.
Liu L, Liu S, Wang C, et al.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2019; (25(5)):197-202 doi:10.1097/RHU.0000000000000810.
PMID: 29975207 - 2
Does daily folic acid supplementation reduce methotrexate efficacy?
Cline A, Jorizzo JL
Dermatology online journal 2017; (23(11)).
PMID: 29447631 - 3
Navigating methotrexate toxicity: Examining the therapeutic roles of folinic acid and glucarpidase.
Chan BS, Bosco AA, Buckley NA
British journal of clinical pharmacology 2025; (91(3)):628-635 doi:10.1111/bcp.16096.
PMID: 38889902 - 4
Fatal low-dose methotrexate toxicity: A case report and literature review.
Ouellette S, Shah R, Razi S, et al.
Dermatologic therapy 2022; (35(12)):e15945 doi:10.1111/dth.15945.
PMID: 36259229 - 5
Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIV.
Freeman ML, Clagett BM, Moisi D, et al.
Frontiers in immunology 2022; (13()):924718 doi:10.3389/fimmu.2022.924718.
PMID: 35967371 - 6
Weekly Folic Acid Is a Convenient and Well-Tolerated Alternative to Daily Dosing in Pediatric Patients with Inflammatory Bowel Disease on Methotrexate.
Temtem TA, Vickers M, Whitworth J
Nutrients 2023; (15(7)) doi:10.3390/nu15071586.
PMID: 37049427 - 7
Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia.
Oosterom N, de Jonge R, Smith DEC, et al.
PloS one 2019; (14(9)):e0221591 doi:10.1371/journal.pone.0221591.
PMID: 31527879 - 8
Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.
Cohen IJ
Cancer chemotherapy and pharmacology 2017; (79(6)):1057-1065 doi:10.1007/s00280-017-3304-y.
PMID: 28455583 - 9
Systematic review of recommendations on the use of methotrexate in rheumatoid arthritis.
Valerio V, Kwok M, Loewen H, et al.
Clinical rheumatology 2021; (40(4)):1259-1271 doi:10.1007/s10067-020-05363-2.
PMID: 32876784 - 10
Analysis of factors influencing target PASI responses and side effects of methotrexate monotherapy in plaque psoriasis: a multicenter study of 1521 patients.
Erduran F, Emre S, Hayran Y, et al.
Archives of dermatological research 2024; (316(6)):278 doi:10.1007/s00403-024-03066-1.
PMID: 38796658 - 11
Reply to Ian J. Cohen.
Aarnivala H, Harila-Saari A, Niinimäki R
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022; (30(3)):1901-1902 doi:10.1007/s00520-021-06781-x.
PMID: 35050382 - 12
Acute bone marrow suppression and gastrointestinal toxicity following acute oral methotrexate overdose.
Isoardi KZ, Harris K, Carmichael KE, et al.
Clinical toxicology (Philadelphia, Pa.) 2018; (56(12)):1204-1206 doi:10.1080/15563650.2018.1484128.
PMID: 29973099 - 13
High-flux hemodialysis as rescue therapy for high-dose methotrexate toxicity: case series and clinical insights.
Tome ACN, Santos KF, Lima EQ, Ramalho RJ
Frontiers in medicine 2025; (12()):1495705 doi:10.3389/fmed.2025.1495705.
PMID: 40160322 - 14
Effect of proton pump inhibitors on high-dose methotrexate elimination: a systematic review and meta-analysis.
Wang X, Song Y, Wang J, et al.
International journal of clinical pharmacy 2020; (42(1)):23-30 doi:10.1007/s11096-019-00958-5.
PMID: 31916121 - 15
Methotrexate Cutaneous Ulceration: A Systematic Review of Cases.
Berna R, Rosenbach M, Margolis DJ, et al.
American journal of clinical dermatology 2022; (23(4)):449-457 doi:10.1007/s40257-022-00692-1.
PMID: 35486323 - 16
Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity - a randomized controlled trial.
Bhargava M, Kopp CR, Naidu S, et al.
Arthritis research & therapy 2023; (25(1)):82 doi:10.1186/s13075-023-03054-2.
PMID: 37208770
This page is for informational purposes only and does not constitute medical advice about your methotrexate regimen. Do not change folic acid or leucovorin or manage a dosing error without guidance from your prescriber, pharmacist, poison center, or emergency team.
Get notified when new evidence is published on Methotrexate toxicity.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.